KHTRF
Price
$4.50
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
390.53M
MEDXF
Price
$2.07
Change
+$0.03 (+1.47%)
Updated
Jul 25 closing price
Capitalization
31.92M
10 days until earnings call
Interact to see
Advertisement

KHTRF vs MEDXF

Header iconKHTRF vs MEDXF Comparison
Open Charts KHTRF vs MEDXFBanner chart's image
Knight Therapeutics
Price$4.50
Change-$0.00 (-0.00%)
Volume$2.5K
Capitalization390.53M
Medexus Pharmaceuticals
Price$2.07
Change+$0.03 (+1.47%)
Volume$19.64K
Capitalization31.92M
KHTRF vs MEDXF Comparison Chart in %
Loading...
KHTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEDXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KHTRF vs. MEDXF commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KHTRF is a Hold and MEDXF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (KHTRF: $4.50 vs. MEDXF: $2.07)
Brand notoriety: KHTRF and MEDXF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: KHTRF: 81% vs. MEDXF: 255%
Market capitalization -- KHTRF: $390.53M vs. MEDXF: $31.92M
KHTRF [@Pharmaceuticals: Other] is valued at $390.53M. MEDXF’s [@Pharmaceuticals: Other] market capitalization is $31.92M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KHTRF’s FA Score shows that 0 FA rating(s) are green whileMEDXF’s FA Score has 0 green FA rating(s).

  • KHTRF’s FA Score: 0 green, 5 red.
  • MEDXF’s FA Score: 0 green, 5 red.
According to our system of comparison, MEDXF is a better buy in the long-term than KHTRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KHTRF’s TA Score shows that 7 TA indicator(s) are bullish while MEDXF’s TA Score has 5 bullish TA indicator(s).

  • KHTRF’s TA Score: 7 bullish, 1 bearish.
  • MEDXF’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, KHTRF is a better buy in the short-term than MEDXF.

Price Growth

KHTRF (@Pharmaceuticals: Other) experienced а +0.54% price change this week, while MEDXF (@Pharmaceuticals: Other) price change was +0.83% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.51%. For the same industry, the average monthly price growth was +11.90%, and the average quarterly price growth was +74.65%.

Reported Earning Dates

MEDXF is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KHTRF($391M) has a higher market cap than MEDXF($31.9M). KHTRF has higher P/E ratio than MEDXF: KHTRF (39.84) vs MEDXF (26.67). KHTRF YTD gains are higher at: 24.765 vs. MEDXF (-14.327). KHTRF has higher annual earnings (EBITDA): 44M vs. MEDXF (14.6M). KHTRF has more cash in the bank: 183M vs. MEDXF (13.1M). MEDXF has less debt than KHTRF: MEDXF (70.1M) vs KHTRF (82.6M). KHTRF has higher revenues than MEDXF: KHTRF (312M) vs MEDXF (108M).
KHTRFMEDXFKHTRF / MEDXF
Capitalization391M31.9M1,226%
EBITDA44M14.6M301%
Gain YTD24.765-14.327-173%
P/E Ratio39.8426.67149%
Revenue312M108M289%
Total Cash183M13.1M1,397%
Total Debt82.6M70.1M118%
FUNDAMENTALS RATINGS
KHTRF vs MEDXF: Fundamental Ratings
KHTRF
MEDXF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
65
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8864
PRICE GROWTH RATING
1..100
5263
P/E GROWTH RATING
1..100
9791
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MEDXF's Valuation (65) in the null industry is in the same range as KHTRF (68). This means that MEDXF’s stock grew similarly to KHTRF’s over the last 12 months.

MEDXF's Profit vs Risk Rating (100) in the null industry is in the same range as KHTRF (100). This means that MEDXF’s stock grew similarly to KHTRF’s over the last 12 months.

MEDXF's SMR Rating (64) in the null industry is in the same range as KHTRF (88). This means that MEDXF’s stock grew similarly to KHTRF’s over the last 12 months.

KHTRF's Price Growth Rating (52) in the null industry is in the same range as MEDXF (63). This means that KHTRF’s stock grew similarly to MEDXF’s over the last 12 months.

MEDXF's P/E Growth Rating (91) in the null industry is in the same range as KHTRF (97). This means that MEDXF’s stock grew similarly to KHTRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KHTRFMEDXF
RSI
ODDS (%)
Bullish Trend 3 days ago
44%
Bullish Trend 3 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
33%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bullish Trend 3 days ago
49%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bullish Trend 3 days ago
42%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
34%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
38%
Bearish Trend 3 days ago
81%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
49%
Bullish Trend 3 days ago
85%
Aroon
ODDS (%)
Bullish Trend 3 days ago
36%
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
KHTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEDXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BPXXY19.030.29
+1.55%
BPER BANCA S.P.A
DIGTF0.01N/A
N/A
Thruvision Group PLC
HXGBF10.86N/A
N/A
Hexagon AB
SRCAF0.08N/A
N/A
Stria Lithium, Inc.
STGXF6.21N/A
N/A
Smartgroup Corp Ltd.

KHTRF and

Correlation & Price change

A.I.dvisor tells us that KHTRF and ESALF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KHTRF and ESALF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KHTRF
1D Price
Change %
KHTRF100%
+0.10%
ESALF - KHTRF
27%
Poorly correlated
N/A
OVATF - KHTRF
25%
Poorly correlated
N/A
TAK - KHTRF
22%
Poorly correlated
N/A
JUSHF - KHTRF
13%
Poorly correlated
+9.15%
HYPMY - KHTRF
8%
Poorly correlated
-4.52%
More

MEDXF and

Correlation & Price change

A.I.dvisor tells us that MEDXF and LBTSF have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MEDXF and LBTSF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEDXF
1D Price
Change %
MEDXF100%
+1.42%
LBTSF - MEDXF
10%
Poorly correlated
N/A
MRMD - MEDXF
9%
Poorly correlated
+11.47%
MKGAF - MEDXF
7%
Poorly correlated
-1.72%
KHTRF - MEDXF
5%
Poorly correlated
+0.10%
MCUJF - MEDXF
4%
Poorly correlated
N/A
More